Canaan VII

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a firm founded in 1987 and based in San Francisco, California. Canaan Partners specializes in investing in innovative entrepreneurs, focusing primarily on the technology and healthcare sectors. The fund emphasizes investments in software and technology, media, and telecommunications. Over its 30 years of operation, Canaan has successfully managed over $5 billion in assets and completed more than 190 exits, demonstrating a strong track record in nurturing and scaling companies. With a team experienced in technology, infrastructure, communications, and life sciences, Canaan is committed to supporting promising ventures across a range of industries, ensuring it targets high-potential opportunities in the United States.

Brent Ahrens

General Partner

Brenton K. Ahrens

General Partner - West Coast

Nandu Anilal

Vice President

John Balen

Partner - West Coast

Stephen Bloch

General Partner - East Coast

Richard Boyle

General Partner - West Coast

Laura Chau

Partner

Brendan Dickinson

General Partner

Rayfe Gaspar-Asaoka

Partner

Julie Papanek Grant

General Partner

Stephen Green

Venture Partner

Wende Hutton

General Partner

Maha Ibrahim

General Partner - West Coast

Deepak Kamra

General Partner - West Coast

Nina Kjellson

General Partner - West Coast

Mark Mangiola

Venture Partner

Jared Newman

Vice President

Julie Papanek

Partner

Guy Russo

General Partner - East Coast

Timothy Shannon

General Partner

Hrach Simonian

General Partner - West Coast

Dana Warren

Venture Partner, East Coast

Bob Williams

Venture Partner - West Coast

Eric Young

Partner and Co-Founder

Past deals in Minnesota

Instrumental

Series C in 2022
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to operate autonomously, learn, and adapt to various processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to address inefficiencies in manufacturing, ultimately saving significant costs related to scrap and rework. Instrumental's software allows manufacturers to quickly identify and resolve issues on their assembly lines, thereby preventing production delays and improving yield rates. The service is employed by leading manufacturers globally and focuses on analytics that provide insights into assembly line performance, allowing engineers to evaluate part dimensions and diagnose problems in real-time without needing physical access to the production environment. Based in Saint Paul, Minnesota, Instrumental combines its software capabilities with a range of consulting and integration services to support both commercial enterprises and government agencies in optimizing their operations.

Relievant

Venture Round in 2020
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to operate autonomously, learn, and adapt to various processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to address inefficiencies in manufacturing, ultimately saving significant costs related to scrap and rework. Instrumental's software allows manufacturers to quickly identify and resolve issues on their assembly lines, thereby preventing production delays and improving yield rates. The service is employed by leading manufacturers globally and focuses on analytics that provide insights into assembly line performance, allowing engineers to evaluate part dimensions and diagnose problems in real-time without needing physical access to the production environment. Based in Saint Paul, Minnesota, Instrumental combines its software capabilities with a range of consulting and integration services to support both commercial enterprises and government agencies in optimizing their operations.

Relievant

Series E in 2018
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

Relievant

Series D in 2016
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

Relievant

Series D in 2012
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

Relievant

Series C in 2009
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

CoAxia

Series D in 2009
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series D in 2008
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

CoAxia

Series C in 2008
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series C in 2007
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

Relievant

Series B in 2006
Relievant Medsystems, Inc. is a medical device company focused on addressing chronic axial low back pain through a minimally invasive procedure known as Intracept. This innovative treatment specifically targets the basivertebral nerve, utilizing radio-frequency energy delivered through a small access tube into the vertebral body to ablate the nerve. The procedure is performed under real-time fluoroscopic guidance, ensuring precision and safety. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic solutions that significantly improve the quality of life for patients suffering from vertebrogenic low back pain.

CoAxia

Series C in 2006
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series B in 2005
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

CoAxia

Series B in 2004
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series A in 2002
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.